Detalles de la búsqueda
1.
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
N Engl J Med
; 381(13): 1201-1214, 2019 09 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31553833
2.
Rates of Postoperative Recurrence of Crohn's Disease and Effects of Immunosuppressive and Biologic Therapies.
Clin Gastroenterol Hepatol
; 19(4): 713-720.e1, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32272248
3.
Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or Cyclosporine.
Clin Gastroenterol Hepatol
; 19(6): 1180-1188.e4, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32777552
4.
Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease.
Gastroenterology
; 158(8): 2123-2138.e8, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32044319
5.
Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 18(5): 1142-1151.e10, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31446181
6.
Ustekinumab Pharmacokinetics and Exposure Response in a Phase 3 Randomized Trial of Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 18(10): 2244-2255.e9, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31816446
7.
No Superiority of Tacrolimus Suppositories vs Beclomethasone Suppositories in a Randomized Trial of Patients With Refractory Ulcerative Proctitis.
Clin Gastroenterol Hepatol
; 18(8): 1777-1784.e2, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31610337
8.
Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease Patients.
J Clin Gastroenterol
; 54(9): 819-825, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31789759
9.
Development and feasibility of a telemonitoring tool with full integration in the electronic medical record: a proof of concept study for patients with inflammatory bowel disease in remission on biological therapy.
Scand J Gastroenterol
; 55(3): 287-293, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32180470
10.
Worries and concerns of inflammatory bowel disease (IBD) patients in Belgium - a validation of the Dutch rating form.
Scand J Gastroenterol
; 55(12): 1427-1432, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33135491
11.
Treatment Algorithm for Mild and Moderate-to-Severe Ulcerative Colitis: An Update.
Digestion
; 101 Suppl 1: 2-15, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31945767
12.
No Change in Determining Crohn's Disease Recurrence or Need for Endoscopic or Surgical Intervention With Modification of the Rutgeerts' Scoring System.
Clin Gastroenterol Hepatol
; 17(8): 1643-1645, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30291910
13.
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease.
Gastroenterology
; 154(5): 1334-1342.e4, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29277560
14.
Impact of endoscopy system, high definition, and virtual chromoendoscopy in daily routine colonoscopy: a randomized trial.
Endoscopy
; 51(3): 237-243, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30646403
15.
Optimising infliximab induction dosing for patients with ulcerative colitis.
Br J Clin Pharmacol
; 85(4): 782-795, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30634202
16.
Efficacy, Pharmacokinetics, and Immunogenicity is Not Affected by Switching From Infliximab Originator to a Biosimilar in Pediatric Patients With Inflammatory Bowel Disease.
Ther Drug Monit
; 41(3): 317-324, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30633088
17.
Short Health Scale: a valid and reliable measure of quality of life in Dutch speaking patients with inflammatory bowel disease.
Scand J Gastroenterol
; 54(5): 592-596, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31106617
18.
Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease.
J Pediatr Gastroenterol Nutr
; 68(6): 847-853, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30633108
19.
Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial.
Gut
; 67(5): 818-826, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28450388
20.
Effect of vedolizumab (anti-α4ß7-integrin) therapy on histological healing and mucosal gene expression in patients with UC.
Gut
; 67(1): 43-52, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27802155